
Keywords: Butein; Rhus verniciflua; Chronic diseases; Prevention; Treatment; 4E-BP1; eIF4E binding protein 1; ACE; angiotensin converting enzyme; ACTA2; alpha-actin-2; AGEs; advanced glycation end products; ALDH1A3; aldehyde dehydrogenase 1 family member A3; ALL; a